ESALY Stock: Eisai Co., Ltd. Stock Price, Analysis & Insights
Get live ESALY stock price $61.51, comprehensive Eisai Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time ESALY stock data and investment insights.
Loading chart data...
Eisai Co., Ltd. (ESALY) Overview
Eisai Co., Ltd. (ESALY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, ESALY trades at $61.51 with a market capitalization of 17.64B . Over the past 52 weeks, ESALY has traded between $36.88 and $73.90 , with the current price positioned at approximately 67% of this range . The...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 17.64B
- Current price: $61.51
- 52-week range: $36.88 - $73.90
- P/E ratio: 20.54
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Headquartered in Tokyo, Japan, Eisai Co., Ltd. is a pharmaceutical company that develops and markets a diverse range of medicinal products within Japan. Its extensive product lineup includes treatments for neurological conditions, such as Aricept for...
Company Information
- CEO
- Haruo Naito
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 11092
Contact Information
- Website
- https://www.eisai.co.jp
- Address
- 4-6-10, Koishikawa
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.5)
✓ Lower volatility stock (Beta: 0.00) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Eisai Co., Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Eisai Co., Ltd.
- ⚠Investors should consider how Eisai Co., Ltd. fits within their overall portfolio allocation
Market Cap
17.64B
P/E Ratio (TTM)
20.54
Beta
0.00
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ESALY with peer companies:
- Price
- $3.50
- Market cap
- 624.32M
- Price
- $1.00
- Market cap
- 758.42M
- Price
- $1.71
- Market cap
- 15.11B
- Price
- $113.13
- Market cap
- 9.32B
- Price
- $26.00
- Market cap
- 984.58M
- Price
- $0.19
- Market cap
- 112.06M
- Price
- $22,005.00
- Market cap
- 8.05B
- Price
- $0.09
- Market cap
- 463.12M
- Price
- $14.00
- Market cap
- 18.13B
- Price
- $143.62
- Market cap
- 8.99B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.